AzTrials
AzTrials

Cleft LipNCT07892963

Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair

A study testing Palatal Nerve Block and Suprazygomatic Maxillary Nerve Block in people with Cleft Lip and Cleft Palate +/- Lip, run by Children's National Research Institute.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will evaluate whether adding a suprazygomatic maxillary nerve block to the standard palatal nerve block improves pain control after cleft palate repair surgery in children. Read more about this study

Who is it for?
Ages 9 months and older
Conditions the study is for
Cleft Lip, Cleft Palate +/- Lip, Pain Management
What is being tested?
Palatal Nerve Block and Suprazygomatic Maxillary Nerve Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
No sites listed yet
Study dates
16 Dec 2026to 16 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 months and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Children undergoing primary cleft palate repair or secondary velopharyngeal insufficiency (VPI) surgery.
  • Eligible to receive regional anesthetic nerve blocks as part of the planned surgical procedure.
  • Parent or legal guardian able and willing to provide informed consent.
  • Participant meets all institutional and surgical criteria for undergoing the planned procedure.

Who cannot join

  • Known allergy, hypersensitivity, or contraindication to the study anesthetic medications.
  • Medical conditions that contraindicate regional anesthetic nerve block procedures.
  • Coagulopathy or bleeding disorder that would increase the risk of nerve block placement.
  • Active infection at or near the planned injection site.
  • Inability of parent or legal guardian to provide informed consent.
  • Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with study assessments.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Albert Oh contact

202-713-8856

About this study

This study will evaluate whether adding a suprazygomatic maxillary nerve block to the standard palatal nerve block improves pain control after cleft palate repair surgery in children. Participants will be randomly assigned to receive either the standard palatal block alone or the standard palatal block combined with a suprazygomatic maxillary nerve block. Both techniques use medications commonly used for pain management during surgery.

The purpose of this study is to determine whether the addition of the suprazygomatic maxillary nerve block reduces postoperative pain, decreases the need for opioid medications, and improves recovery after cleft palate repair. Researchers will compare pain scores, medication use, recovery outcomes, and any treatment-related complications between the two groups.

Information collected from this study may help identify the most effective regional anesthesia approach for children undergoing cleft palate repair and may improve postoperative pain management and patient recovery.

Being tested
Palatal Nerve Block, Suprazygomatic Maxillary Nerve Block
Keywords
Nerve Block, Plastic Surgery, Craniofacial Surgery, Anesthesiology
Medical subject headings
Cleft Lip, Agnosia, Surgical Wound Dehiscence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Palatal Nerve BlockProcedure or surgery

    Regional anesthetic block of the palate performed during cleft palate or velopharyngeal insufficiency surgery using local anesthetic. This procedure serves as the standard pain management approach and is intended to provide perioperative analgesia and reduce postoperative pain.

  • Suprazygomatic Maxillary Nerve BlockProcedure or surgery

    Regional anesthetic block of the maxillary nerve performed via a suprazygomatic approach using local anesthetic in addition to the standard palatal nerve block. The procedure is intended to enhance perioperative analgesia, decrease postoperative pain, and reduce postoperative opioid requirements following cleft palate or velopharyngeal insufficiency surgery.

Study groups in NCT07892963
Study groupRoleWhat they receive
Standard Palatal Nerve BlockExperimentalParticipants receive the standard palatal nerve block performed during cleft palate surgery.
Receives: Procedure: Palatal Nerve Block
Standard Palatal Nerve Block Plus Suprazygomatic Maxillary Nerve BlockExperimentalParticipants receive the standard palatal nerve block plus a suprazygomatic maxillary nerve block during cleft palate surgery.
Receives: Procedure: Suprazygomatic Maxillary Nerve Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain Scores

    Postoperative pain will be assessed using age-appropriate validated pain scales following cleft palate repair or velopharyngeal insufficiency surgery. Pain scores will be compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block to evaluate the effectiveness of the additional regional anesthesia technique.

    Measured: Within the first 24 hours following surgery

Secondary outcomes (1)
  1. Postoperative Opioid Consumption

    Total postoperative opioid medication use will be recorded and compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block. This outcome will assess whether the additional regional anesthesia technique reduces the need for opioid analgesics following surgery.

    Measured: Within the first 24 hours following surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2026
  2. Study start16 Dec 2026 (estimated)
  3. Primary completion16 Dec 2027 (estimated)
  4. Study completion16 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07892963
Sponsor's protocol ID
STUDY00001302
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
23 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with researchers outside of the study team. Data collected for this study contain protected health information and were obtained under informed consent and institutional review board requirements that do not include plans for external sharing of individual participant-level data.

Questions about this trial

What is this clinical trial studying?

A study testing Palatal Nerve Block and Suprazygomatic Maxillary Nerve Block in people with Cleft Lip and Cleft Palate +/- Lip, run by Children's National Research Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Logan Stratton (443-922-6012, lstratton@childrensnational.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain Scores (time frame: Within the first 24 hours following surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in